The company has also received the tentative approval from the USFDA to market Lurasidone Hydrochloride Tablets in the strengths of 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg.
Original source: https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-to-market-doxazosin-tablets/68269975?utm_source=RSS&utm_medium=ETRSS